Veterans' PTSD drug trial seeks 40 participants
NCT ID NCT04452500
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tests a new drug called CORT108297 that blocks the stress hormone cortisol, aiming to reduce PTSD symptoms in veterans. About 40 veterans with PTSD will take the drug or a placebo for several weeks. Researchers will measure symptom changes and side effects to see if the drug is safe and helpful for future larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Francisco VA Medical Center, San Francisco, CA
RECRUITINGSan Francisco, California, 94121-1563, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tuscaloosa VA Medical Center, Tuscaloosa, AL
RECRUITINGTuscaloosa, Alabama, 35404, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.